These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
108 related items for PubMed ID: 3109094
1. Electron microscopic investigations of the cyclophosphamide-induced lesions of the urinary bladder of the rat and their prevention by mesna. Themann H, Oberdorf E, Brock N, Pohl J. Urol Int; 1987; 42(1):37-43. PubMed ID: 3109094 [Abstract] [Full Text] [Related]
2. Prevention of cyclophosphamide cystitis with 2-mercaptoethane sodium sulfonate: a histologic study. Freedman A, Ehrlich RM, Ljung BM. J Urol; 1984 Sep; 132(3):580-2. PubMed ID: 6433044 [Abstract] [Full Text] [Related]
3. Efficacy of mesna in preventing further cyclophosphamide-induced hemorrhagic cystitis. Luce JK, Simons JA. Med Pediatr Oncol; 1988 Sep; 16(6):372-4. PubMed ID: 3143903 [Abstract] [Full Text] [Related]
8. Cyclophosphamide-induced Down-Regulation of Uroplakin II in the Mouse Urinary Bladder Epithelium is Prevented by S-Allyl Cysteine. Abdi SA, Najmi AK, Raisuddin S. Basic Clin Pharmacol Toxicol; 2016 Dec; 119(6):598-603. PubMed ID: 27234646 [Abstract] [Full Text] [Related]
9. [Prevention of urotoxic complications during therapy with cytostatics. The problem of the interaction between sodium-II-mercaptoethanesulfonate and cyclophosphamide]. Possinger K, Ehrhart H, Misera C, Hartenstein R. Fortschr Med; 1981 Oct 22; 99(40):1650-2. PubMed ID: 6795099 [No Abstract] [Full Text] [Related]
11. Prevention of urinary bladder tumors in cyclophosphamide-treated rats by additional medication with the uroprotectors sodium 2-mercaptoethane sulfonate (mesna) and disodium 2,2'-dithio-bis-ethane sulfonate (dimesna). Habs MR, Schmähl D. Cancer; 1983 Feb 15; 51(4):606-9. PubMed ID: 6401591 [Abstract] [Full Text] [Related]
12. [Architectural ultrastructure of the urinary bladder epithelium. II. Changes in the urine-blood barrier in the contracted and distended state in the normal and inflammatory bladder]. Konishi T. Hinyokika Kiyo; 1988 Jan 15; 34(1):23-31. PubMed ID: 3376802 [Abstract] [Full Text] [Related]
13. The development of mesna for regional detoxification. Brock N, Pohl J. Cancer Treat Rev; 1983 Sep 15; 10 Suppl A():33-43. PubMed ID: 6414694 [No Abstract] [Full Text] [Related]
14. Comparison of mesna with forced diuresis to prevent cyclophosphamide induced haemorrhagic cystitis in marrow transplantation: a prospective randomised study. Hows JM, Mehta A, Ward L, Woods K, Perez R, Gordon MY, Gordon-Smith EC. Br J Cancer; 1984 Dec 15; 50(6):753-6. PubMed ID: 6437430 [Abstract] [Full Text] [Related]
18. Contribution of flavonoid antioxidants to the preventive effect of mesna in cyclophosphamide-induced cystitis in rats. Ozcan A, Korkmaz A, Oter S, Coskun O. Arch Toxicol; 2005 Aug 15; 79(8):461-5. PubMed ID: 15800758 [Abstract] [Full Text] [Related]
19. The use of sodium 2-mercaptoethane sulfonate to prevent cyclophosphamide cystitis. Ehrlich RM, Freedman A, Goldsobel AB, Stiehm ER. J Urol; 1984 May 15; 131(5):960-2. PubMed ID: 6423841 [Abstract] [Full Text] [Related]
20. Mesna and oxazaphosphorine cancer chemotherapy. Shaw IC. Cancer Treat Rev; 1987 Dec 15; 14(3-4):359-64. PubMed ID: 3125971 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]